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We applied a combination of rational design and directed evolution (DE) to Bacillus
subtilis p-nitrobenzyl esterase (pNBE) with the goal of enhancing organophosphorus
acid anhydride hydrolase (OPAAH) activity. DE started with a designed variant, pNBE
A107H, carrying a histidine homologous with human butyrylcholinesterase G117H to
find complementary mutations that further enhance its OPAAH activity. Five sites were
selected (G105, G106, A107, A190, and A400) within a 6.7Å radius of the nucleophilic
serine Oγ. All 95 variants were screened for esterase activity with a set of five substrates:
pNP-acetate, pNP-butyrate, acetylthiocholine, butyrylthiocholine, or benzoylthiocholine.
A microscale assay for OPAAH activity was developed for screening DE libraries.
Reductions in esterase activity were generally concomitant with enhancements in OPAAH
activity. One variant, A107K, showed an unexpected 7-fold increase in its kcat/Km for
benzoylthiocholine, demonstrating that it is also possible to enhance the cholinesterase
activity of pNBE. Moreover, DE resulted in at least three variants with modestly enhanced
OPAAH activity compared to wild type pNBE. A107H/A190C showed a 50-fold increase
in paraoxonase activity and underwent a slow time- and temperature-dependent change
affecting the hydrolysis of OPAA and ester substrates. Structural analysis suggests that
pNBE may represent a precursor leading to human cholinesterase and carboxylesterase 1
through extension of two vestigial specificity loops; a preliminary attempt to transfer the -
loop of BChE into pNBE is described. Unlike butyrylcholinesterase and pNBE, introducing a
G143H mutation (equivalent to G117H) did not confer detectable OP hydrolase activity on
human carboxylesterase 1 (hCE1). We discuss the use of pNBE as a surrogate scaffold
for the mammalian esterases, and the importance of the oxyanion-hole residues for
enhancing the OPAAH activity of selected serine hydrolases.
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INTRODUCTION
Butyrylcholinesterase (BChE; EC 3.1.1.8) and its genetically
engineered variants are being developed as therapeutic enzyme
“bioscavengers” of organophosphorus acid anhydrides (OPAA) to
prevent or treat OPAA poisoning (Millard et al., 1995a; Doctor
and Saxena, 2005; Saxena et al., 2006) and also have been inves-
tigated to reverse cocaine addiction (Xie et al., 1999; Zheng
and Zhan, 2008; Masson and Rochu, 2009). OPAA compounds
(Figure 1) are highly toxic or lethal primarily because they
Abbreviations: AtCh, acetylthiocholine; BME, beta-mercaptoethanol; BtCh,
butyrylthiocholine; BzCh, benzoylthiocholine; CD, circular dichroism; CE, car-
boxylesterase; DMSO, dimethylsulfoxide; DTNB, dithiobis(2-nitrobenzoic acid);
DTT, dithiothreitol; EB, equilibration buffer; hCE1, human carboxylesterase
1; IPTG, isopropyl-β-thiogalactoside; -loop, residues between Cys-67-Cys-94
(TcAChE numbering); OPAA, organophosphorus acid anhydride inhibitors;
OPAAH, organophosphorus acid anhydride hydrolase; paraoxon, diethyl p-
nitrophenylphosphate; pNBE, p-nitrobenzylesterase; pNPA, p-nitrophenyl acetate;
pNPB, p-nitrophenyl butyrate; SDS-PAGE, sodium dodecyl sulfate polyacrylamide
gel electrophoresis; WT, wild type.
rapidly, completely, and irreversibly inhibit essential biological
stores of synaptic acetylcholinesterase (AChE; EC 3.1.1.7) leading
to rigid paralysis, asphyxiation, and seizures (Shih et al., 2003).
OPAA are archetypical irreversible inhibitors of serine hydrolases
(Scheme S1), but in some cases the inhibition is slowly reversed
(half-time of hours or days) because the phosphylated esterase
undergoes spontaneous hydrolysis of the covalent adduct to yield
reactivated enzyme (Main, 1979). Human BChE has been pro-
posed as a prophylactic antidote because it is able to react rapidly
with essentially all toxic pesticides and military “nerve agents”
in the blood stream to prevent inhibition of AChE (reviewed in
Ashani, 2000; Doctor and Saxena, 2005; Nachon et al., 2013).
The primary limitation to employing natural human BChE as
a therapeutic is that each enzyme molecule can react only once
with an OPAA inhibitor molecule and therefore will require an
estimated dose of 200–1820mg/70 kg of BChE to confer protec-
tion against 2 × LD50 of most nerve agents (Ashani, 2000; Geyer
et al., 2010). For therapeutic enzyme bioscavengers, catalyzed
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FIGURE 1 | Structures of carboxylester substrates and organophosphate
inhibitors. The G-type agents, Soman and Sarin, carry neutral R-groups while
the V-type inhibitors, VX and echothiophate, contain cationic R-groups which
mimic choline. Simulants which carry poorer leaving groups are commonly
used in screening and include paraoxon, DFP, and echothiophate. OP are
effective inhibitors because they mimic the substrates of the esterases which
they inhibit. The transition states of carboxylesters are tetrahedral, while
those of OP are pentavalent. Accommodation of the various R-groups of the
OP is therefore determined empirically using a series of inhibitors with
R-groups varying in size or charge.
turnover could significantly enhance the rate of OPAA hydrol-
ysis and reduce the amount of enzyme needed for protection.
Using rational protein design, Millard and colleagues introduced
a single histidine residue (G117H) into the oxyanion hole of
human BChE to increase the rate of spontaneous reactivation and
thereby convert OPAAs from inhibitors into xenobiotic substrates
which could be hydrolyzed by the mutant enzyme (Millard et al.,
1995a; Lockridge et al., 1997). G117H enhanced the hydrolysis
of paraoxon or echothiophate by 100,000-fold (Lockridge et al.,
1997), and a secondmutation (G117H/E197Q) permitted hydrol-
ysis of even the most toxic nerve agents known (soman, sarin, or
VX) by increasing the rate of spontaneous reactivation and simul-
taneously decreasing an unwanted side reaction known as “aging”
(Scheme S1) (Shafferman et al., 1996; Millard et al., 1998).
Cholinesterase “aging” is an irreversible dealkylation of the
phosphylated serine that proceeds through enzyme-catalyzed for-
mation of a carbocation leaving group (Scheme S1) (Michel
et al., 1967; Li et al., 2007; Masson et al., 2010). Dealkylation
results in an anionic phosphoester adduct that is resistant
to nucleophilic attack. Aging involves the same cholinesterase
residues that stabilize the binding of positively charged leaving
groups of choline esters or V-type nerve agents (VX and VR),
including, Glu-197, and Trp-82 within the -loop of BChE
(Figure S1, Figure 2) (Hosea et al., 1996; Masson et al., 1997a;
Kua et al., 2003). Cholinesterases are predominantly found in
higher eukaryotes and the -loop may have arisen specifi-
cally to bind and hydrolyze choline esters (Figure 2) because
very few esterases react efficiently with cationic ligands (Cousin
et al., 1996). Structurally related esterases [such as human car-
boxylesterase (hCE)] that lack the homologous Trp do not exhibit
significant cholinesterase activity and do not undergo comparable
aging after OPAA inhibition (Hemmert et al., 2010).
Human BChE and its variants offer several important advan-
tages as therapeutic enzymes (Doctor and Saxena, 2005), and
transgenic animals bearing the G117H BChE variant have shown
limited resistance to OPAA poisoning (Wang et al., 2004). A pegy-
lated WT BChE enzyme (Protexia®) has also shown protection
in vivo against soman and VX (Lenz et al., 2007; Mumford and
Troyer, 2011). In addition to BChE, other enzymes such as AChE,
hCE, or the metalloenzyme paraoxonase (PON1) have shown
promise as bioscavengers. Both BChE (Saxena et al., 2006; Lenz
et al., 2007; Mumford and Troyer, 2011) and PON1 (Costa et al.,
1990; Li et al., 1995; Valiyaveettil et al., 2011) have shown limited
protection against nerve agent and OP-pesticide intoxication in
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FIGURE 2 | Comparison of pNBE and BChE. (A) Structure of pNBE (PDB
1QE3) (Spiller et al., 1999). (B) Active site of WT pNBE. The catalytic
triad, Glu-310, His-399, Ser-189, is shown in lime. The residues selected
for DE (G105, G106, A107, A190, and A400) are shown in blue ball
and stick representation. The A107 residue is equivalent to G117 in
butyrylcholinesterase. Structured residues between Cys-61 and Cys-82
corresponding to the -loop of BChE are shown in red. pNBE and BChE
are structurally similar and two structures can be superposed with an rmsd
= 2.1Å over 350 Cα . (C) Structure of BChE (PDB 1P0M) (Nicolet et al.,
2003). The -loop of BChE is shown in red, choline is shown in dark
green. The narrow gorge of BChE is partially formed by the -loop. The
catalytic triad is found at the bottom of the gorge. (D) The -loop forms
part of the choline binding site and carries Trp-82; this residue forms an
energetically significant cation-pi interaction with cationic choline substrates
(Ordentlich et al., 1993, 1995). Glu-197 also plays an important role in
choline binding (Ordentlich et al., 1995; Masson et al., 1997b), and a
residue equivalent to Glu-197 is present in pNBE. (E) Partial sequence
alignment of pNBE, the pNBE -loop variant, hCE1, TcAChE, BChE, and
BChE G117H variant. The -loop residues between Cys-65 and Cys-92 are
shown in red and are unstructured in pNBE [PDB 1QE3 (Spiller et al.,
1999)]. The -loop of BChE was transferred to pNBE to form the chimeric
variant. The -loop is well formed in hCE1, AChE, and BChE. The Trp
residue of the choline binding site is notably absent from pNBE and hCE1.
The roles of these residues in catalysis are shown in Figure S1.
animal models. PON1 has been mutated to hydrolyze both G-
type (soman and sarin) and V-type (VX) nerve agents (Cherny
et al., 2013; Kirby et al., 2013). While PON1 is able to hydrolyze
selected OP nerve agents at much faster rates in vitro than G117H
or hCE, the Km values for WT PON1 and its variants are in
the millimolar range (Otto et al., 2010). High turnover num-
bers can be achieved by PON1 at saturating concentrations of
OPAA (Kirby et al., 2013) but these concentrations are well above
the levels of nerve agent that can be tolerated in living systems
(LDsoman50 = 113μg/kg= 0.00062mmol/kg in mice; Maxwell and
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Koplovitz, 1990) and the IC50 of AChE (ICsoman50 = 0.88–2.53 nM,
ICsarin50 = 3.27–6.15 nM; Fawcett et al., 2009). Consequently, each
class of enzyme bioscavenger has advantages and disadvantages
(Trovaslet-Leroy et al., 2011), and efforts to improve binding and
expand the substrate specificities of several candidates is ongoing
(Otto et al., 2010; Trovaslet-Leroy et al., 2011; Kirby et al., 2013;
Mata et al., 2014).
Unfortunately, the modest OPAA rate enhancements con-
ferred on BChE by the G117H mutation have not been improved
upon for the past two decades (Millard et al., 1995a, 1998;
Lockridge et al., 1997). Emerging technologies for protein engi-
neering, especially directed evolution (DE) or biological incorpo-
ration of unnatural amino acids into the active site to improve
OPAAH rates, have not been applied to cholinesterases largely
because these eukaryotic enzymes have complex tertiary struc-
tures with extensive post-/co-translational modifications (e.g.,
glycosylation, GPI-anchor, disulfides) and, therefore, are not
amenable to facile manipulation and expression in prokaryotic
systems (Masson et al., 1992; Ilyushin et al., 2013). In contrast,
DE has been successfully applied to paraoxonase using variants of
human PON1 which produce soluble and active enzyme in E. coli
(Aharoni et al., 2004).
To explore a combination of rational design and DE meth-
ods on a bacterial enzyme that shares the cholinesterase fold,
we selected Bacillus subtilis p-nitrobenzyl esterase (pNBE, EC
3.1.1.-; Spiller et al., 1999). We chose pNBE as a surrogate scaffold
because: (i) the X-ray structures suggest that pNBEmay represent
a prokaryotic structural precursor to the cholinesterases (AChE
or BChE) (Spiller et al., 1999), as well as to the related family of
hCE (Figure S1); (ii) pNBE appears to have a more open active
site (Figure 2) and was shown previously to permit DE modifica-
tions of substrate specificity loops without compromising protein
folding (Giver et al., 1998; Spiller et al., 1999); and (iii) pNBE,
like the family of hCE (Fleming et al., 2007), lacks the amino
acid present in BChE and AChE that is known to promote the
deleterious aging reaction (e.g., W82 of BChE) (Masson et al.,
1997a). We created and screened a library of 162 pNBE variants
to identify mutations which could enhance OPAAH activity and
expand the substrate and inhibitor specificities of this enzyme.
The mutations were then transferred to hCE1 to determine if
pNBE could be used as a surrogate scaffold. We identified one
pNBE variant with a three-order of magnitude enhancement in
somanase activity compared with WT. Unexpectedly, the variant
with the largest enhancement in OPAA activity also underwent
a slow time- and temperature-dependent change in activity. We
correlate our results with the solved X-ray structures of pNBE to
understand possible mechanisms for engineered OPAAH activ-
ity, and discuss complications posed by hysteretic forms in the
kinetic and structural analysis of mutant pNBE, AChE and BChE
(Masson et al., 2005; Badiou et al., 2008; Lushchekina et al., 2014).
MATERIALS AND METHODS
MATERIALS
BugBuster™ and the pTriEx-3 vector were from Novagen (San
Diego, CA). Chelating Sepharose, Q-Sepharose, and PD-10
columns were from GE Healthcare Life Sciences (Piscataway,
NJ). QuikChange™ kits were purchased from Stratagene (La
Jolla, CA). Benzoylthiocholine (BzCh) was purchased from
TCI America (Portland, OR). The 96-well, clear polystyrene
HIS-Select® High Capactiy (HC) Nickel Coated Plates were
purchased from Sigma. All other chemicals were purchased from
Sigma. Echothiophate was from Wyeth Pharmaceuticals Inc.
(Philadelphia, PA).
CONSTRUCTION OF THE DE LIBRARY
Five sites in pNBEwere selected for the directed-evolution library:
G105, G106, A107, A190, and A400. The Cα of each of the five
residues was between 5.0 and 6.7 Å from the Ser-189-Oγ. The
A107H mutation was also present in each starting variant with
the exception of the twenty variants of A107. The plasmids of
the DE library were synthesized by GeneArt, Inc. (Regensberg,
Germany). The pNBE expression vector (pTriEx-3, Novagen Inc.)
contained an N-terminal PreScission™ Protease cleavage site and
a hexa-histidine tag preceding the pNBE sequence.
CONSTRUCTION OF THE CHIMERIC BChE/pNBE-LOOP VARIANT
The megaprimer method (Sarkar and Sommer, 1990) was used
to construct the chimeric BChE-pNBE variant. A megaprimer
containing a sequence from one of the known cholinesterase sub-
strate specificity loops, in this case the “-loop” of BChE, was
used to replace the homologous sequence in pNBE. The variant
was sequenced to confirm the substitution. Protein sequences are
included in the Supplemental Information.
SMALL SCALE PROTEIN EXPRESSION AND PURIFICATION
All 95 constructs in the DE library expressed soluble protein
under these conditions. Four milliliter cultures of LB containing
100μg/mL Ampicillin were inoculated with frozen glycerol stocks
and grown for 3 h at 37◦C with shaking (200 rpm). Cultures were
induced with 1μL of 1.0M IPTG overnight at 17◦C. Bacteria
were pelleted and then lysed in 0.5mL Lysis Buffer (87.5%
BugBuster™, 2mM BME, 50mM Tris pH 7.6, 375mM NaCl)
at room temperature (17–22◦C) for at least 1 h. Lysed bacteria
were centrifuged at 4800 × g for 10min. Clarified lysates were
then loaded onto nickel-charged Chelating Sepharose columns
(0.5mL slurry per disposable column) equilibrated with three
column volumes of equilibration buffer (EB; 50mM Tris pH 7.6,
500mM NaCl, 2mM BME). After the supernatant was loaded,
the columns were washed again with three column volumes of
EB. To elute contaminants, the columns were washed with three
column volumes of EB containing 60mM Imidazole. Proteins
were isocratically eluted with EB containing 300mM Imidazole.
Imidazole readily reacts with the carboxyl ester substrates used to
assay the enzyme; thus, it was necessary to buffer exchange the
enzymes with BioMax (10,000 NMWL) ultrafiltration units three
times with 50mM HEPES pH 7.0, 150mM NaCl to remove the
imidazole. Purified enzymes ran as single bands in SDS-PAGE gels
and were judged to be ≥90% pure.
LARGE SCALE PROTEIN EXPRESSION AND PURIFICATION
Large scale preps of selected variants were used for kinetic analy-
sis. LB (1–3 L) containing 100μg/mL Ampicillin was grown with
shaking at 37◦C and induced overnight with 0.2mM IPTG at
17◦C. Bacterial pellets were lysed in 40mL of lysis buffer contain-
ing∼30mg lysozyme and then sonicated for 1min in an ice bath.
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Lysates were clarified by centrifugation (30min at 20,500 × g).
Supernatants were loaded onto a 20mL nickel-charged Chelating
Sepharose column. After loading, the column was washed with
EB containing 60mM imidazole until the A280 returned to a
level baseline. Protein was eluted with EB containing 300mM
imidazole. Fractions containing pNBE were combined and dia-
lyzed against 50mM Tris pH 7.6, 150mM NaCl, 2mM BME.
Protein was loaded onto a 30mL Q-Sepharose column and eluted
between 260 and 400mM NaCl during the gradient.
CARBOXYLESTERASE ASSAYS
Steady state kinetic parameters for the enzyme catalyzed hydroly-
sis of p-nitrophenyl acetate (pNPA) and p-nitrophenyl butyrate
(pNPB) were measured in triplicate at room temperature in
50mM HEPES 7.0, 150mM NaCl (405 nm). Substrate and
inhibitors were dissolved in DMSO and accounted for less than
1% of the reaction volume.
Acetylthiocholine (AtCh), butyrylthiocholine (BtCh), or ben-
zoylthiocholine (BzCh) hydrolysis was measured in triplicate
at 412 nm in cuvettes or a plate reader using Ellman’s reagent
(0.5mM DTNB) (Ellman et al., 1961). All assays were done in
1× Sorensen’s buffer (53.4mM Na2HPO4, 13.4mM KH2PO4)
pH 7.4 at room temperature (22 ± 2◦C). An extinction coeffi-
cient of 13.6mM−1cm−1 was used for calculations. One Unit of
activity (U) was defined as 1μmol product produced per min,
and specific activity (S.A.) was defined as Units per milligram of
enzyme (U/mg).
PRIMARY ASSAY FOR SCREENING
HIS-Select® plates were washed once with 200μL of binding
buffer (50mM Hepes pH 7.0, 150mM NaCl). Each his-tagged
protein (∼25mU) in the same buffer (100μL) was added to two
wells and allowed to bind for 1 h at 37◦C. All wells contained
enzyme after each plate setup. The OPAA inhibitor was added
(0.5–5μL) to one of the two wells and incubated for 10min at
room temperature. Cautionary note: the OPAA compounds used
in this study are highly toxic and must only be handled with ade-
quate legal authority, training, and safety precautions. Liquid was
removed by a multichannel pipettor, and plates were washed four
times with 200μL of appropriate reaction buffer. Buffer (90 or
95μL) and 0.5M EDTA (10 or 5μL) were then added to each
well to elute the protein. Plates were left at room temperature
or at 37◦C, and aliquots of enzyme (10μL) were removed over
time and assayed in separate 96-well plates using 5mM pNP-
butyrate in binding buffer. Activity was measured at 4–6 time
points to confirm reactivation of a single clone. For the clones
which reactivated in the 96-well assay, large scale preps were then
used to more accurately quantitate the enhancements in the rates
of reactivation.
LARGE SCALE DISCONTINUOUS SPONTANEOUS REACTIVATION
ASSAYS
Spontaneous reactivation was measured essentially as previously
described (Millard et al., 1995a; Lockridge et al., 1997). Briefly,
an aliquot of uninhibited enzyme or the OPAA-inhibited (>95%
inhibited) enzyme was loaded onto PD-10 gel filtration columns
equilibrated with 50mM Tris pH 7.6, 150mMNaCl, 2mM BME.
At time t = 0, the columns were loaded, and the protein was
rapidly eluted; fractions were incubated at 37◦C, activity wasmea-
sured for the uninhibited enzyme, and inhibited enzyme and
percentages of reactivated enzyme were calculated. The pseudo
first order rate constant for spontaneous reactivation due to the
hydrolysis of the serinyl-phosphate adduct, kr, was determined by
fitting the data to the following equation (Wang and Braid, 1967;
Main, 1979):
At = Amax
(
1 − e−krt
)
where At is the percent reactivated at time t and Amax is the
maximal percent reactivated at final observation time >> t0. For
the A107H/A190C variant, which exhibited a form of hysteresis
(Hanozet et al., 1981; Uto and Brewer, 2008), the enzyme was
incubated at 37◦C for at least 2 h after exchanging the buffer using
a PD-10 column equilibrated with 50mM Tris pH 7.6, 150mM
NaCl, 2mM BME. The enzyme was then inhibited, and rates of
reactivation were measured.
ORGANOPHOSPHATE INACTIVATION
Aliquots of enzyme were inhibited with different concentrations
of inhibitor, and the activity was measured discontinuously using
pNP-butyrate at different time points. Data were plotted and fit
to a single exponential decay equation to obtain kobs, the observed
first order rate constant. A secondary plot was used to determine
the maximal rate constant for inactivation, k2, at infinite inhibitor
concentration. The rate constant was determined by plotting kobs
vs. [I] concentration and fitting the data to the following equa-
tion (or by extrapolation using the double-reciprocal form of the
equation) from Kitz and Wilson (1962):
kobs = k2
1 + Kp/[I]
The apparent bimolecular rate constant, ki, for formation of the
covalent E-I complex from free enzyme and free inhibitor was
calculated according to the following:
ki = k2/Kp
where Kp is a Michaelis-type constant for the inhibitor.
RESULTS
SELECTION OF RESIDUES FOR DIRECTED EVOLUTION (DE)
Prior to the creation of the DE library, we produced the A107H
pNBE variant by analogy with BChE G117H (Millard et al.,
1995a; Lockridge et al., 1997) and demonstrated that it possesses
increased OPAAH activity (Table 1). The OPAAH activity of the
pNBE A107H variant was found to be acid-catalyzed and 4-fold
higher at pH 7.0 than at pH 7.6 (Table 1). At pH 7.0 the reactiva-
tion rate of the A107H variant was 46-fold higher when compared
with WT and 18-fold higher at pH 7.6.
To identify mutations which could further enhance the
OPAAH activity of A107H, we constructed a DE library of dou-
ble mutants at five different sites: A107H/G105X, A107H/G106X,
A107H/A190X, and A107H/A400X (where X stands for any
amino acid). We also examined the A107X single mutation vari-
ants of pNBE. Each residue selected for DE (G105, G106, A107,
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Table 1 | pH dependence of reactivation rates after inhibition with
ethyl paraoxon.
Enzyme Inhibitor pH % Reactivation kreactivation
(1/h)
WT Paraoxon 7.6 110±10% 0.03±0.01
Paraoxon 7.0 91±8 0.05±0.01
Paraoxon 6.5 88±6 0.035±0.007
Paraoxon 6.0 52±2 0.042±0.005
A107H Paraoxon 7.6 102±5 0.53±0.09
Paraoxon 7.0 90±10 2.3±0.3
BChE  Loop
Mutant with A107H
Paraoxon 7.6 86±4 1.0±0.1
Rates were measured in 50mM Tris pH 7.6, 150mM NaCl, 2mM BME; 50mM
Hepes 7.0, 150mM NaCl, 2mM BME; 50mM MES pH 6.5, 150mM NaCl, 2mM
BME; or 50mM MES pH 6.0, 150mM NaCl, 2mM BME at 37 ◦C.
A190, or A400) was within 6.7 Å of the Oγ of the nucleophilic Ser-
189 in pNBE and was conserved in BChE and hCE1 (Figure 2).
Based upon the X-ray structure of pNBE, we concluded that the
backbone NH groups of G106, A107, and A190 form a 3-point
oxyanion hole (Figure S1). Gly-105 is situated near the oxyan-
ion hole, but is not part of the oxyanion hole. The corresponding
G105A variant in human AChE affected the turnover number of
the substrate, but not the Km; this substitution was suggested to
affect the conformational mobility of the adjacent residues of the
oxyanion hole (Ordentlich et al., 1998). The side-chain of Ala-
190 was hypothesized to exert an effect on the polarity and/or
orientation of the backbone NH groups of A107 and G106 and
thereby affect TS stabilization. The oxyanion hole is the primary
source of transition state stabilization in serine hydrolases (Bryan
et al., 1986). The A190 side-chain is situated directly behind the
loop carrying A107 and G106. The Cβ of A190 is 3.6–3.7 Å away
from the backbone NH of A107 and G106 (Figures S1B,D). The
A400 residue is located on a loop of pNBE. The A400T muta-
tion in pNBE was shown previously to project into the active site
(6.7 Å from the Ser-189-Oγ) and enhance the thermostability of
pNBE in DE experiments by Spiller et al. (1999). Spiller et al.
proposed that the Thr side-chain of residue-400may stabilize His-
399 of the catalytic triad. A400 was also near the choline leaving
group in overlays of pNBE with a BChE-choline co-crystal struc-
ture (1P0M) (Nicolet et al., 2003) (Figure S1C). We selected it
here to find variants which might stabilize a particular conformer
of His-399 or stabilize the alkyl groups of the soman pinacolyl
group, the DFP iso-propyl groups, or, alternatively, the cationic
choline-like leaving groups of V-type nerve agents and simulants
(e.g., echothiophate).
SUBSTRATE SPECIFICITY
Five substrates were tested with single point assays and the DE
library of variants to determine if the mutations altered substrate
specificities: pNPA, pNPB, AtCh, BtCh, and BzCh (Figure S2).
WT pNBE had the highest substrate specificity for pNP-butyrate
as judged by the bimolecular rate constant, kcat/Km = 14, 000 ±
2000min−1 mM−1. A detectible level of CE activity is needed
to measure reactivation rates by the discontinuous method.
All 95 of the variants had detectable levels of CE activity when
pNP-butyrate was used as the substrate. This allowed the use of
a common substrate for activity measurements at different time
points during reactivation experiments. No significant enhance-
ment in the substrate specificities of the DE library variants for
pNPA or pNPB was observed.
CHARACTERIZATION OF VARIANTS WITH ENHANCED
CHOLINESTERASE ACTIVITY
Ideally, universal OP bioscavenging enzymes should scavenge
both G-type and V-type agents (Figure 1). V-type agents, such
as VX and VR, and V-type simulants like echothiophate mimic
positively charged choline esters (Scheme S1) and readily inhibit
AChE and BChE. Echothiophate and VX are slowly turned over
by the BChEG117H variant (Millard et al., 1995a). Cholinesterase
activity can only be found in a subset of esterases, typically those
of eukaryotes (Cousin et al., 1996). The cationic choline esters are
accommodated by two key residues at the bottom of the gorge
of BChE and AChE, Trp-84/82, and Glu-199/197 (TcAChE/BChE
numbering) (Ordentlich et al., 1995). These residues also play a
role in the binding specificity of tetrahedral cationic V-type agents
in AChE (Hosea et al., 1996), as well as in the unfavorable “aging”
process (Shafferman et al., 1996). A residue within the peripheral
anionic site (PAS) at the top of the gorge, Asp-72/70, also plays a
role in V-type agent binding (Hosea et al., 1996), but is relatively
distant from the choline binding pocket (∼7Å); hCE1 and pNBE
lack a homologous Asp residue (Figure 2E). Since hCE1 and
pNBE are structurally similar to AChE and BChE (Figure S1A)
but are not known to hydrolyze choline esters or become inhibited
by V-type agents, we also examined the DE library for the devel-
opment of cholinesterase activity and susceptibility to inhibition
by echothiophate (last section).
Cholinesterases contain an omega-shaped loop between the
disulfide bonded cysteines, Cys-67 and Cys-94 (TcAChE num-
bering) (Figure 2, Figure S1). The -loop carries Asp-72/70
and Trp-84/82 of the choline binding site. To determine if a
cholinesterase -loop could be inserted, we substituted the -
loop sequence of BChE into the pNBE A107H variant. The
chimeric variant folded as a functional esterase (Table 2). The Km
and kcat values for pNPA were similar to those of the WT enzyme.
However, the loop insertion alone did not confer cholinesterase
activity, and the kcat and Km for BzCh and BtCh were similar
to those of the A107H pNBE variant (Table 3). Thus, the DE
library was made with the A107H pNBE variant, rather than the
loop-insertion variant.
All 95 variants were initially examined for cholinesterase activ-
ity using single point assays (Figure S2). To determine if the
pNB-esterase variants could bind and turnover cationic OPAA
like echothiophate, we first looked for cholinesterase activity.
AChE, BChE, hCE1, and pNB-esterase all share the same fold
(Figure S1A). Steady state kinetic parameters for the variants
which showed significant increases in cholinesterase activity are
shown in Table 3. Unexpectedly, the variant which showed the
largest increase in cholinesterase activity was a single mutant with
a positively charged lysine residue, A107K. This variant showed a
7-fold increase in the kcat/Km and an 8-fold increase in the kcat of
benzoylthiocholine, while the Km was similar toWT. Substitution
of Arg (A107R) in place of Lys did not significantly enhance
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benzoylthiocholinesterase activity, but resulted in a 3-fold higher
Km suggesting that the larger Arg side-chain may interfere with
substrate binding. Substitution of A107 by the neutral residue,
Gln, and by hydrophobic residues yielded similar Km values and
no enhancement of kcat. Substitution of A107 by His also did not
confer significant cholinesterase activity.
Butyrylthiocholinesterase activity was the highest in the
A107S, A107T, A107H/A190R, and A107H/A400D variants
Table 2 | Substrate specificities of pNBE and selected variants.
Enzyme Substrate kcat (1/min) Km (mM) kcat/Km
(1/min*mM)
WT pNPA 370±30 1.2±0.3 300±80
pNPB 1100±40 0.08±0.01 14000±2000
A107H pNPA 130±10 5.6±0.7 23±3
pNPB 520±20 0.12±0.02 4300±700
A107H/A190C pNPA 70±10 0.9±0.4 70±30
pNPB 7±1 0.3±0.1 20±10
A107H/A400T pNPB 460±10 0.12±0.02 3800±600
A107H/A400V pNPB 510±30 0.17±0.03 3000±600
BChE  Loop
Mutant with
A107H
pNPA 185±6 1.6±0.1 116±8
pNPA (pNP-acetate) and pNPB (pNP-butyrate) assays were run in 50mM HEPES
pH 7.0, 150mM NaCl, 22 ± 3 ◦C. All enzymes had the N-terminal His-tag.
(Table 3). A400 was predicted to be near the choline group
from structural overlays. The A107H/A400D variant had a 2-
fold increase in the kcat/Km for benzoylthiocholine and 9-fold
increase for butyrylthiocholine when compared to A107H; how-
ever, the Km values for all of the variants were >1mM, indi-
cating that the pNBE variants could only weakly bind cationic
substrates.
OPTIMIZATION OF THE PRIMARY ASSAY USED FOR SCREENING THE
DE LIBRARY
To develop a micro-scale assay for reactivation, (His)6-tagged
enzymes were bound to nickel-coated 96-well plates. To maintain
near physiological conditions, the pH was kept at 7.6; measure-
ment at a sub-optimal pH also allowed for a longer time period
to carry out the subsequent steps. Two wells were coated with
enzyme (≤0.025U per well) for each variant to measure the
activity of the uninhibited and inhibited enzyme. The enzyme
was inhibited on the plate, and excess enzyme and inhibitor
were removed. The plates were then washed with buffer. Rates
of reactivation were comparable after one, two, or four washes.
For the plate assay, four washes were done to ensure removal
of the OPAA. After washing away excess inhibitor and unbound
enzyme, the enzyme was eluted from the plate with 50mMEDTA.
Imidazole was avoided because it readily reacted with the ester
substrates (Bruice and Schmir, 1956). Aliquots were removed and
assayed over time. The rate constant for reactivation for A107H
using themicroscale assay (k2washesr = 0.22 ± 0.08 h−1; k4washesr =
0.3 ± 0.2 h−1) was comparable with that determined using a gel
Table 3 | Steady state kinetic parameters for selected pNBE variants of the DE library.
Substrate Benzoylthiocholinea Butyrylthiocholineb
Enzyme kcat(1/min) Km(mM) kcat/Km(1/min*mM) kcat (1/min) Km(mM) kcat/Km(1/min*mM)
WT 70±9 1.2±0.3 58±16 130±10 5.4±0.8 24± 4
A107H 13±1 0.6±0.2 22±7 35±8 17±5 2.0±0.9
A107H Loop 8±1 0.9±0.3 9±3 10.4±0.9 8.0±0.7 1.3±0.2
A107K 570±50 1.4±0.2 410±70 >20 >8c –
A107Q 40±4 1.0±0.2 39±9 40±10 19±7 2± 1
A107R 90±20 5±1 20±6 >50 >8c –
A107S 39±9 1.4±0.6 30±10 780±30 14.4±0.7 54± 3
A107T 36±3 0.6±0.2 60±20 240±30 11±2 22± 5
A107V 38±4 0.5±0.2 80±30 56±8 8±2 7± 2
A107Y 21±2 0.6±0.1 35±8 45±5 6.0±0.9 7± 1
A107H/A190G 29±4 0.9±0.3 30±10 50±30 11±7 5± 4
A107H/A190R 12±1 0.6±0.2 20±7 200±30 13±2 15± 3
A107S/A190G 23±4 2.2±0.6 10±3 90±30 11±4 9± 4
A107V/A190G 21±2 0.6±0.1 35±7 45±5 6.0±0.9 8± 1
A107H/A400D 80±10 2.1±0.6 40±10 190±60 11±5 18± 9
A107H/A190S/A400S 6.4±0.9 0.8±0.2 9±3 115±14 9±1 13± 3
Benzoylthiocholine and butyrylthiocholine were used as substrates. Specific activities of the other variants are shown graphically in the Supplemental Information.
aBenzoylthiocholine has limited solubility in DMSO, the highest substrate concentration tested was 2.5mM.
bButyrylthiocholine was also a poor substrate of pNBE, and Km values were in the mid-millimolar range. Saturation was not achieved at the highest substrate
concentration tested (8mM). Km values were extrapolated from double reciprocal plots.
cSaturation was not achieved at [S] = 8mM, and the plot of velocity vs. [S] was linear. Extrapolated Km’s exceeded 40mM.
www.frontiersin.org July 2014 | Volume 2 | Article 46 | 7
Legler et al. Protein engineering of p-nitrobenzyl esterase
FIGURE 3 | Reactivation data from the primary assay using a 96-well
His-Select® plate. Aliquots of enzyme were removed once at each time
point and assayed for CE activity using pNP-butyrate. Enzymes were
reactivated in 50mM Tris pH 7.6, 150mM NaCl. Reactivation rates measured
using the assay for (A) the A107H/A190C (E10) variant, (B) the WT pNBE, and
(C) the A107H variant. (D) Example of reactivation rates using single point
measurements for selected variants at different time points using the 96-well
plate assay. Some variants showed full reactivation by the first time point
while others progressively reactivated over longer time periods. (E)
Reactivation rates measured for the A107H variant using the 96-well plate
assay after one (◦) or two (•) washes to remove the inhibitor, Paraoxon. The
reactivation of the WT enzyme is also shown after one () or two () washes
for comparison. Rates were measured in 50mM Tris pH 7.6, 150mM NaCl
at 37◦C.
filtration column (kr = 0.53 ± 0.09 h−1) at the same pH and
temperature. Data collected using the microscale assay and 2
washes are shown in Figure 3. The DE library was screened one to
two times with the various OP. From the first round, 26 of the 95
variants were more carefully examined with large scale preps and
kinetic experiments. Error in the values of kr was higher using
data collected from the microscale assay, suggesting that it is bet-
ter suited for large-scale screening than for precise determination
of kinetic parameters.
For slow and moderate rates of reactivation the microscale
assay was useful as a primary assay for the exploration of OP
inhibitors and reaction conditions (Figure 3D). The microscale
assay helped identify the variants which could reactivate faster
than the single variant, A107H. The vast majority of the vari-
ants did not show significant enhancements in OPAAH activity
using either the discontinuous assay or a continuous assay with
paraoxon; these results are consistent with other applications of
DE (Dalby, 2003; Goldsmith and Tawfik, 2013). Using the OPAA
activity of A107H as a screening threshold, approximately 3% of
the library was advanced for further testing.
The half time of reactivation for pNBE A107H was t1/2 =
78min. Thus, observation of full reactivation at ∼20min indi-
cated that the kr was ≥1.9 h−1 or ≥4-fold faster than the A107H
variant. Reactivation rates for the top hits were more accurately
measured using large scale preps of the enzymes and gel filtration
columns.
It should be noted that the measurement of reactivation rates
alone cannot identify a mechanism of OP resistance. Resistance
to OP inhibition can arise from reduced binding of OP, poor
stabilization of the TS, poor accommodation of the R-groups
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as the pentavalent TS forms, or increased OPAAH activity.
These possibilities can only be distinguished by additional kinetic
experiments. These methods are routinely used to characterize
pesticide resistance mechanisms in insecticide-insensitive AChE
variants (Newcomb et al., 1997; Temeyer et al., 2012; Zhang et al.,
2012).
VARIANTS WITH ENHANCED OPAAH ACTIVITY
After screening the library of 95 variants for reactivation after
paraoxon inhibition, three variants were found to reactivate faster
than the A107H variant: A107H/A400M (H2), A107H/A190G
(F2), and A107H/A190C (E10). The A107H/A190C double vari-
ant was found to have the greatest rate enhancement. Relative
to the WT pNBE (kParaoxonr = 0.03 ± 0.01 h−1), the rate constant
for reactivation following paraoxon inhibition was 18-fold higher
for the A107H variant (kParaoxonr = 0.53 ± 0.09 h−1), and 50-fold
higher for the A107H/A190C double variant (kr = 1.5 ± 0.2 h−1)
(Table 4). Consistent with the aliesterase hypothesis (Oppenoorth
and van Asperen, 1960), the turnover number for pNBE-catalyzed
Table 4 | Rates of reactivation after ethyl paraoxon inhibition
measured for the DE variants at 37◦C in 50mM Tris pH 7.6, 150mM
NaCl, 2mM BME.
Enzyme CLONE kreactivation (1/h) % Reactivation
A107 D3 0.03±0.01 110±10
A107C D4 0.15±0.03 40±3
A107D D5 0.31±0.02 90±2
A107E D6 0.048±0.006 46±4
A107F D7 0.023±0.004 130±10
A107G D8 0.0114±0.0009 70±4
A107H – 0.53±0.09 102±5
A107I D9 0.013±0.004 70±4
A107K D10 0.04±0.02 25±6
A107L D11 0.030±0.005 25±2
A107M D12 0.06±0.03 90±10
A107N E1 0.04±0.01 60±10
A107Q E3 0.05±0.02 110±10
A107R E4 0.14±0.03 27±2
A107S E5 0.03±0.01 100±10
A107T E6 0.034±0.006 40±5
A107V E7 0.22±0.03 28±1
A107Y E9 0.012±0.003 7±1
A107H/A190C E10 1.5±0.2a 62±3
A107H/A190V G2 0.4±0.1 73±9
A107H/A190G F2 0.7±0.3 90±10
A107H/A190H F3 0.10±0.02 66±8
A107H/A190M F7 0.3±0.2 17±5
A107H/A400W H10 0.4±0.2 130±50
A107H/A400M H2 1.0±0.2 97±7
A107H/A400V H9 0.6±0.1 130±20
A107H/A190C/A400T A8 0.43±0.07 92±7
A107H/A190C/A400T A8 1.0±0.1a 75±5
A107H/A190C/A400M C4 1.0±0.1a 75±5
aEnzymes were heated at 37 ◦C prior to reactivation.
hydrolysis of the ester substrates, pNPA or pNPB, progressively
decreased as OP-hydrolase activity increased (Table 2). Thus,
as OP-hydrolase activity is evolved to accommodate a pentava-
lent TS of an OP, the carboxylesterase activity and stabilization
of a tetrahedral transition state is lost (Oppenoorth and van
Asperen, 1960). For soman, the largest rate enhancements were
observed (Table 5). Somanase activity was not observed in the
G117H BChE single mutant (Millard et al., 1998) until a sec-
ond mutation was added (G117H/E197Q). In pNBE, the A107H
mutation (equivalent to G117H in BChE) enhanced the rate of
spontaneous reactivation after soman inhibition, but an addi-
tional rate enhancement was achieved with the A107H/A190C
variant. The kr for A107H (kSomanr = 0.7 ± 0.1 h−1) was 700-fold
above WT (kSomanr = 0.001 ± 0.004 h−1) and 4000-fold higher
for the A107H/A190C variant (kSomanr = 4 ± 1 h−1). The trends
were similar to those observed with paraoxon (Table 4). A190 in
pNBE is also at a different location than E197 in BChE, and rate
enhancements in OP-hydrolase activity have not been reported
from mutations at this site (Figure S1D).
The variant which displayed the greatest rate enhancements
in OP-hydrolase activity, A107H/A190C, exhibited unexpected
kinetic complexity consistent with a slow conformational change
in the enzyme. Pre-incubation of the purified A107H/A190C
enzyme at 37◦C in the absence of any substrate or inhibitor caused
a subsequent time-dependent increase in Vmax for CE activity
and the reactivation rate constants for selected OPAA (Figure S3).
Maximal CE activity could be achieved by pre-incubating the
enzyme at 37◦C in 50mM Tris pH 7.6, 150mM NaCl, 2mM
BME for≥2 h. Likewise, pre-equilibrating A107H/A190C to 37◦C
for ≥2 h doubled the apparent dephosphonylation rate con-
stant following paraoxon or soman inhibition (Tables 4, 5). The
dephosphorylation rate constant following DFP inhibition was
not similarly affected. The DFP-inhibited A107H/A190C vari-
ant reactivated 5-fold more slowly than did A107H (Table 6),
and no further increases could be gained by heating the enzyme.
We also tested the triple mutant, A107H/A190C/A400M, for
temperature-dependent hysteresis but found no significant effect
on reactivation (Table 5).
Several mutations at the A190 and A400 positions were com-
patible with A107H. The backbone NH groups of A107 and
A190 form part of the oxyanion hole. Changes in the polarity of
these NH groups have been proposed to enhance OPAAH activity
Table 5 | Rates of reactivation after inhibition with soman.
Enzyme kreactivation (1/h) % Reactivated Fold
increase
WT 0.001±0.004 <4% after 5.5 h –
A107H 0.7±0.1 106±8 700
A107H/A190Ca 1.8±0.2 44±5 1800
A107H/A190Cb 4±1 43±6 4000
A107H/A190C/A400Ma 0.7±0.2 20±2 700
A107H/A190C/A400Mb 1.2±0.5 17±2 1200
aWithout heating prior to inhibition.
bWith 2 h of heating at 37 ◦C prior to reactivation at 37 ◦C.
www.frontiersin.org July 2014 | Volume 2 | Article 46 | 9
Legler et al. Protein engineering of p-nitrobenzyl esterase
(Yao et al., 2012). Hydrophobic mutations A400M and A400V
within the loop slightly enhanced the rate of reactivation. The
A107H/A400M (H2) and A107H/A190G (F2) double mutants
showed the second largest enhancements, but additive effects were
not observed in the A107H/A190C/A400M variant or any other
triple mutant.
Having constructed a DE library with all 20 amino acids at
position A107, we also determined if other residues at this posi-
tion were more effective than histidine in catalyzing reactivation.
In addition to A107H, the variants A107C, A107D, and A107V
showed apparent reactivation rate enhancements for selected
OPAA compared with WT pNBE. Of this group, however, only
A107H and A107D fully reactivated after inhibition by paraoxon
(Table 4). This result is similar to what was reported by Schopfer
et al. (2004). Schopfer observed OP hydrolase activity in G117D,
G117E, and L286H variants of BChE.
TRANSFER OF MUTATIONS ONTO hCE1
The spontaneous reactivation rate constant for WT hCE1 inhib-
ited with paraoxon was low (Table 7). This is consistent with
reports that WT hCE1 can be irreversibly inhibited by stereoiso-
mers of soman or cyclosarin (Hemmert et al., 2010). The
mutation equivalent to G117H in BChE was made in hCE1
(G143H), but did not enhance or confer OPAAH activity
(Table 7). The hCE1 loop residues 302–320 (equivalent to 276–
290 in BChE) that form the acyl pocket differ significantly
among hCE1, pNBE, and BChE. In snake AChE, the single
G122Hmutation (homologous to BChE G117H) did not increase
OPAAH activity; only introduction of two additional mutations
(G122H/Y124Q/S125T) permitted engineering of limited sponta-
neous reactivation following slow inhibition with selected OPAA
(Poyot et al., 2006). Thus, while pNBE is more similar to hCE1
Table 6 | Rates of reactivation at pH 7.6 after inhibition with DFP.
Enzyme kreactivation (1/h) % Reactivated
A107H 0.6±0.1 110±10
A107H/A190C 0.13±0.08 150±40
A107H/A190Ca 0.17±0.01 69±2
A107H/A190G 0.63±0.06 108±3
aHeated for 3 h at 37 ◦C prior to reactivation.
Table 7 | Rates of reactivation of hCE1 after inhibition with paraoxon.
Enzyme pH kreactivation (1/h) % Reactivated
hCE1 WT 7.0 0.078±0.006 92±3
7.6 0.102±0.006 98±3
hCE1 G143H 7.0 0.025±0.008 45±8
7.6 0.03±0.03 15±2
hCE1 G143H/A222C 7.0 0.007±0.003 120±60
7.6 0.009±0.007 11±8
in terms of substrate specificity, the utility of pNBE as a surrogate
scaffold still remains to be explored.
INHIBITION BY PARAOXON
Reliable measurement of IC50 or Ki values requires enzyme con-
centrations below the Ki. For enzymes with IC50 values in the nM
range, only upper limits can typically bemeasured. Theminimum
amount of enzyme needed to obtain a signal/noise ratio >2 was
0.5 nM of enzyme. The observed IC50 (0.37 nM) for paraoxon
was almost equal with the enzyme concentration (0.5 nM), sug-
gesting that the IC50 ≤ 0.5 nM. Thus, pNBE is an effective scav-
enger of paraoxon at low nM concentrations. Similar values have
been reported for AChE with soman and sarin [ICsoman50 = 0.88–
2.53 nM, ICsarin50 = 3.27–6.15 nM (Fawcett et al., 2009)].
INHIBITION BY ECHOTHIOPHATE
pNBE and hCE1 share the cholinesterase fold, but lack
cholinesterase activity. To determine if V-type inhibitors with
choline-like leaving groups could be accommodated by variants,
we screened the library with echothiophate and looked for irre-
versible inhibition. Through one mutation, A107S, we were able
to achieve a 50-fold increase in the rate of inhibition. However,
for the pNBE variants tested, the Kp values remained high (mil-
limolar range) compared with those of natural cholinesterases
(Table 8).
DISCUSSION
Arnold and colleagues have shown that B. subtilis pNBE can be
modified to achieve increased thermostability, broadened sub-
strate specificity, or improved reactivity in organic solvents using
DE (Giver et al., 1998; Spiller et al., 1999; Brustad and Arnold,
2011). DE is a large scale site-directed mutagenesis experiment
where selected residues are mutated to all 20 amino acids, or ran-
dom mutations are introduced to alter catalytic activity and/or
substrate specificity (Brustad and Arnold, 2011). This process
generates 20 different enzymes for each selected site or thou-
sands of variants with mutations at random sites (reviewed by
Goldsmith and Tawfik, 2013); screening thousands of mutants
is typically impractical. Several approaches are available for
Table 8 | Inhibition by echothiophate.
Enzyme k2 (1/min) Kp (mM) k2/Kp (1/min*mM)
A107H 0.013±0.005 9±4 0.0014± 0.0008
A107K 0.014±0.005 10±4 0.0014± 0.0008
A107S 0.7±0.4 10±7 0.07± 0.06
A107T 0.06±0.05 11±8 0.006± 0.006
A107R 0.02±0.04 >5 0.00045± 0.00009a
A107Q 0.079±0.008 3±1 0.026± 0.009
A107V 0.10±0.02 20±4 0.005± 0.001
A107Y 0.06±0.04 20±1 0.004± 0.004
Rates were measured using 1× Sorensen’s buffer pH 7.4 at room temperature
(22 ± 2 ◦C).
aInhibition was observed; however, the intercept could not be determined
accurately from a distant extrapolation (very weak binding).
Frontiers in Chemistry | Chemical Biology July 2014 | Volume 2 | Article 46 | 10
Legler et al. Protein engineering of p-nitrobenzyl esterase
generating large libraries of mutants, but there are far fewer val-
idated methods for selecting mutants with the desired activity.
Here we constructed a “focused” DE library, utilized a bacterial
homolog as a surrogate scaffold, and restricted the mutations
to residues within a 7 Å radius of the nucleophilic serine. While
pNBE, AChE, BChE, and hCE1 share a common fold (Figure S1),
it is known that the single mutation analogous to G117H in BChE
does not confer OP-hydrolase activity in AChE (Ordentlich et al.,
1998; Poyot et al., 2006). Based upon substrate specificities, we
show that pNBE and hCE1 are similar (this paper). However,
when we examined the A107H variant of pNBE and the G123H
variant of hCE1, we found that the histidine substitution only
conferred OP-hydrolase activity in pNBE. Our preliminary results
demonstrate that pNBE is a suitable prokaryotic scaffold for engi-
neering improved reactivity with a range of OPAA inhibitors
including soman, but that it is sufficiently different from hCE1
that additional mutations would be required.
While a significant enhancement in the rate of reactivation
after soman inhibition was achieved (103-fold increase, Table 5)
the pNBE A107H variant did not achieve the same rates of reac-
tivation as the BChE G117H variant [kBChE-Somanr = 6000 ± 600
1/min (Millard et al., 1998) vs. k
pNBE-E10-Soman
r = 0.07 ± 0.02
1/min]. This may in part be due to the more open active site of
pNBE (Figure 2A) vs. the tunnel-like gorge of AChE and BChE.
One other complication was a slow time- and temperature-
dependent change in activity in the variant which had the largest
enhancement (103-fold) in OP-hydrolase activity. Various forms
of hysteresis in AChE and BChE have been observed kinetically
(Masson et al., 2005; Badiou et al., 2008; Masson and Lockridge,
2010; Lushchekina et al., 2014), and possibly structurally (Nachon
et al., 2011). Non-linear kinetic curves for BChE G117H also
were observed with selected substrates (Millard et al., 1995b).
Hysteresis affecting CE activity of both BChE and AChE (Masson
et al., 2005; Badiou et al., 2008; Masson and Lockridge, 2010;
Lushchekina et al., 2014) and OP-hydrolase activity (Masson,
2012) has been reported and has been attributed to the flipping of
the His of the catalytic triad. A pronounced lag phase (3min) was
observed in the BChE A328Cmutant at 25◦C (Masson, 2012); the
side chain of this residue is near His-438 of the triad (∼4.5 Å). In
pNBE the mechanism of hysteresis may or may not be the same
since the A190 side chain is behind the oxyanion hole residues
and is relatively distant from His-399 (>7Å) (Figure S1). If the
His of the catalytic triad is involved, however, the methionine
residue in the A107H/A190C/A400M variant which did not dis-
play hysteresis may stabilize a particular rotamer of His-399. This
mutant displayed a lower percentage of reactivated enzyme after
soman inhibition when compared with A107H/A190C (Table 5)
suggesting that conformational changes may be important in the
mechanism of reactivation.
Hysteresis is rarely considered during DE screening, but can
limit achievable rates of hydrolysis. It also complicates the inter-
pretation of site-directed mutagenesis and structural studies since
the crystallized structure may (or may not) represent the cat-
alytically competent state. We observed kinetic complexity in the
A107H/A190C pNBE variant that affected both esterase and OP-
hydrolase activity. This suggests the involvement of a residue(s)
which plays a role in both esterase and OP-hydrolase activity.
INTRODUCTION OF OPAAH ACTIVITY TO pNBE
The overarching goal of developing a nerve agent bioscavenger
is to find or engineer a biocompatible enzyme that rapidly binds
and hydrolyzes a broad range of neutral (G-type agents) and pos-
itively charged (V-type) OPAA under physiological conditions
where the inhibitor is present at sub-micromolar concentrations.
Cholinesterases react rapidly with all known OPAA nerve agents,
but effectively remain inhibited irreversibly due to the stability of
the OPAA-enzyme complex.
Introducing a single His (G117H) into human BChE converts
the enzyme into a modest OPAAH by increasing the sponta-
neous reactivation rate constant while retaining reactivity with a
broad range of inhibitors (Millard et al., 1995a; Lockridge et al.,
1997). Follow-on attempts to incorporate His-117 into human or
Bungarus fasciatus AChE were relatively unsuccessful (Poyot et al.,
2006). pNBE is the second esterase to show an enhancement in
OPAAH activity by introduction of a single His (A107H corre-
sponds to G117H) and is significantly more amenable to E. coli
expression.
Lockridge and colleagues rationally designed and tested more
than 60 double or triple mutants of human BChE based upon
the initial success with His-117, but none of these variants
improved upon the OPAAH activity of G117H (Lockridge et al.,
1997; Schopfer et al., 2004). We find a similar result using DE
with pNBE. Although enhancements of spontaneous reactivation
compared to WT were measured following paraoxon inhibi-
tion for pNBE A107D, A107V or A107C, the histidine mutant
(A107H) showed the fastest and most complete dephosphory-
lation (Table 4). pNBE A107D is homologous with the blowfly
CE G137D mutant that was isolated by screening OP-resistant
populations of Lucilia cuprina for naturally occurring variants of
G117H (Newcomb et al., 1997). A107D showed enhanced spon-
taneous reactivation compared with WT, but the turnover rates
with paraoxon were slower than those of either pNBE A107H or
the blowfly CE G137D (cf. Table 4 and Kirby et al., 2013).
Cholinesterases and carboxylesterases must stabilize a tetrahe-
dral transition state to catalyze carboxyl ester hydrolysis, whereas
the transition state of an organophosphate is generally a pentava-
lent trigonal bipyramid. Consequently, all attempts to engineer
OPAAH activity into these enzymes must accept a significant
risk of concomitant loss of natural esterase activity. Oppenoorth’s
“aliesterase hypothesis” was based upon this observed interchange
in substrate specificities (Oppenoorth and van Asperen, 1960).
Our results with pNBE generally confirmed this hypothesis with
the trend showing that mutations increasing OPAAH activity also
showed decreasing carboxylesterase activity (Tables 1–7).
The pNBE A107H/A190C variant showed a slow time- and
temperature-dependent increase in CE activity and the rate of
spontaneous reactivation following inhibition with paraoxon or
soman (Figure S3; Tables 4, 5), but not with DFP (Table 6). DFP,
unlike soman or paraoxon, has two bulky R-groups (Figure 1)
which may restrict the pNBE active site from reaching the
temperature-induced conformational change required for the
higher level of activity. It has been shown that the DFP reaction
significantly alters the conformation of the acyl pocket loop of
AChE (Millard et al., 1999; Hornberg et al., 2007). The cor-
responding loop of pNBE is predicted to be nearby His-107
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(Figure 2). Thus, the catalytically competent conformer of the
histidine or hydrolytic water molecule may be affected by con-
formational changes in the loop. The simultaneous mutation of
two residues (A107/A190) may permit subtle, local movements of
the NH groups of the oxyanion hole that are sufficient to enhance
catalysis (Yao et al., 2012). Alternatively, the double mutant may
have more distal effects to structure the disordered loops of WT
pNBE. It was shown previously that mutations which thermally
stabilize the enzyme also increase the optimal temperature for
pNBE carboxylesterase activity (Giver et al., 1998); the omega
loop of the thermal stable pNBE variant (PDB 1C7I) is structured
(Spiller et al., 1999).
IMPORTANCE OF THE OXYANION HOLE
Much of the catalytic power of serine hydrolases derives from the
oxyanion hole (Bryan et al., 1986; Zhang et al., 2002; Warshel,
2003; Bobofchak et al., 2005), and we hypothesize that the same
is true for engineered OPAAH activity. Millard and colleagues
originally proposed the spontaneous reactivation of G117H was
acid catalyzed andmight involve a direct H-bond from the imida-
zolium to the phosphonyl (double bond) oxygen to stabilize the
dephosphylation transition state, or an indirect steric effect that
distorts the preformed electrostatic environment of the oxyanion
hole and thereby permits the catalytic triad His-438 to catalyze
reactivation (Millard et al., 1995a, 1998). Related and alterna-
tive mechanisms subsequently have been proposed (Lockridge
et al., 1997; Newcomb et al., 1997; Albaret et al., 1998; Schopfer
et al., 2004; Poyot et al., 2006; Nachon et al., 2011; Yao et al.,
2012), supported, or refuted based upon analogy with follow-
on His-117 mutations to related enzymes, molecular modeling
studies (Amitay and Shurki, 2009; Yao et al., 2012) or static,
medium resolution X-ray crystal structures (Masson et al., 2007);
however, the actual enzyme mechanism of G117H remains unre-
solved.
Our studies on the structurally homologous pNBE mutants
may provide useful data for ongoing efforts to elucidate the
G117H mechanism. First, like G117H, placing a histidine residue
at the homologous A107H position in the oxyanion hole
enhanced OPAAH activity with a range of inhibitors (Tables 4,
5). Second, OPAAH activity increased as the pH decreased from
7.6 to 7.0, consistent with a mechanism that is acid-catalyzed.
Third, the A190C mutation further enhanced the rate of reactiva-
tion of the A107Hmutation. The NH group of A190 forms part of
the 3-point oxyanion hole, and the side chain would be expected
to point away from the oxyanion. Finally, we observed a slow
time- and temperature-dependent change in carboxylesterase and
OPAAH activity of the A107H/A190C variant that may be con-
sistent with a conformational change or some other reversible
modification in the free enzyme which enhances the role of these
residues in catalysis. Additional work is required to determine
if these observations can be translated to improve human BChE
G117H activity.
INTRODUCTION OF LIMITED CHOLINESTERASE ACTIVITY
One objective of this work was to determine if cholinesterase
activity could be introduced into pNBE. The active site cavity
of pNBE is formed by four loops that are largely disordered in
the WT enzyme crystal structure, viz. residues 64–71 (unstruc-
tured) and 413–417 (unstructured) on one side of the active
site, and 316–320 (unstructured) and 260–268 (structured) on
the other side (Spiller et al., 1999). It appears that these flexible
loops become longer, more differentiated and ordered through
evolution to form the substrate specificity loops observed in
the X-ray structures of AChE and BChE. One side becomes the
cholinesterase “acyl pocket loop,” which we have shown pre-
viously to have reversible conformational flexibility in Torpedo
californica (Tc) AChEwhen binding selected OPAA (Millard et al.,
1999; Hornberg et al., 2007). The other side develops the so-called
-loop carrying Trp-84 (TcAChE numbering; Trp-82 in BChE),
a residue that complements trimethyl or choline-like substrate
leaving groups.
Residues corresponding to the cholinesterase -loop are dis-
ordered in the structure of WT pNBE [PDB 1QE3 (Spiller et al.,
1999)]. Both pNBE and hCE1 lack the critical Trp-84 side chain
(Figure 2E) (Satoh and Hosokawa, 1995; Imai et al., 2006), and
this probably explains why these enzymes are relatively poor
at binding cationic substrates (e.g., ATCh and BTCh; Table 3)
or echothiophate (Table 8). Our initial experiment to insert the
entire -loop into pNBE is a first step in evolving the bacte-
rial enzyme toward a cholinesterase. The loop was accepted by
the pNBE fold and had little or no effect on the reactivity of
the enzyme with neutral substrates or inhibitor; however it also
did not result in detectable activity with positively charged sub-
strates (Table 3). While this rational design attempt with the
-loop failed to increase cholinesterase activity, the focused DE
exploration succeeded in finding A107K which demonstrated an
almost 10-fold increase in its specificity constant for benzyolthio-
choline compared with WT.
COMPARISON OF pNBE AND hCE1
Human carboxylesterase has been proposed as an alternative or
adjunct bioscavenger to the cholinesterases because hCE1 is abun-
dant in human liver, binds and hydrolyzes some neutral OPAA
nerve agents, and does not undergo significant aging after inhibi-
tion with the most deadly OPAA nerve agent, soman (Hemmert
et al., 2010). However, the primary limitation to using hCE as
a nerve agent bioscavenger is the slow reaction rates with pos-
itively charged OPAA. In our study, cholinesterase activity could
be introduced into pNBE by the A107Kmutation, but the amount
was still several orders of magnitude below that of cholinesterases
and the mutation had no effect on the bimolecular rate constant
for inhibition by a cationic OPAA (echothiophate; Table 8). More
importantly, the G143Hmutation did not confer OPAAH activity
in hCE1 (Table 7).
In summary, along with its primary sequence and struc-
tural homology to the cholinesterases and the shared use of a
rare Glu residue instead of Asp in the catalytic triad, we have
shown that B. subtilis pNBE can accommodate the cholinesterase
-loop without detriment to protein folding or endogenous
esterase activity. We have also identified an unexpected point
mutation (A107K) that significantly increases turnover of a pos-
itively charged substrate. Moreover, like BChE but not AChE
or hCE1, the pNBE structure accepts substitutions (A107H
or A107H/A190C) corresponding with G117H that confer
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significant OPAAH activity, thereby expanding the enzyme’s nat-
ural substrate specificity to include phosphoric and phosphonic
acid esters. Taken together, these results suggest to us that pNBE is
an excellent prokaryotic scaffold for follow-on DE studies, as well
as other methods like incorporation of unnatural amino acids,
that can inform new pathways for continued engineering of useful
cholinesterase and/or OPAAH activity within the α/β-hydrolase
superfamily.
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A graph of the esterase activities of the individual mutants
in the DE library, evidence of reversible hysteresis, and sequence
alignments of the enzymes discussed in this study are included in
the Supplemental Information.
Scheme S1 | Organophosphate inhibition, spontaneous reactivation, and
aging.
Figure S1 | Acylation-the first step in the catalytic cycle. (A) The serine
hydrolases AChE (2ACE), BChE (1P0M), hCE1 (2HRR), and pNB-esterase
(1QE3) all share a common fold, but have very different substrate
specificities. This is in part due to residues within the -loop (colored red)
which form part of the choline binding pocket in AChe and BChE. The
equivalent loop in pNBE is disordered in the crystal structure 1QE3. (B)
The acylation step and active site of pNBE. Residues of the catalytic triad
are boxed. (C) The acylation step and active site of BChE. The cationic
choline ester is accommodated by Glu-197 and Trp-82. Trp-82 of the
-loop makes an important cation-pi interaction with the choline ester and
V-type agents (VX and VR) which mimic choline esters. (D) Alternate
views of the Ala-190 side chain. A190 is behind the loop of the oxyanion
hole residues G106 and A107.
Figure S2 | Specific activities (S.A., U/mg) for all 95 variants in the DE
library using five substrates: pNPA, pNPB, benzoylthiocholine,
butyrylthiocholine, and acetylthiocholine. S.A. from single point assays
were measured using 5, 1, 2.5, 2.5, and 2.5mM of the substrates,
respectively. In well D3 is the WT pNBesterase enzyme (where A107 is an
alanine). For all other mutants the A107H mutation is present in
combination with the denoted mutation. For the A107X mutants (where X
= any amino acid), only the single mutation is present. Note, the y-scale
has been adjusted for some graphs. For variants with no visible bars,
values near the spontaneous rate of hydrolysis were measured and
plotted. One substrate, pNPB, was hydrolyzed at detectable levels for all
of the mutants. The S.A. were needed to determine the number of Units
per well to use in the microscale reactivation rate experiments described.
Steady state kinetic parameters were measured for selected variants
which showed enhancements in esterase activity and are described in
Tables 2, 3. Reductions in carboxylesterase activity were expected for
variants which had acquired OP-hydrolase activity [Aliesterase Hypothesis
(Oppenoorth and van Asperen, 1960)]. SDS-PAGE gel showing the purity
of 10 variants purified using small scale preps and single columns.
Figure S3 | Effect of hysteresis on carboxylester hydrolysis. The E10
A107H/A190C double variant showed a 6-fold increase in its
carboxylesterase activity after elution from a PD-10 column during 37◦C
incubation periods. For assays, 10μL of the enzyme was added to a 1mL
reaction volume, and rates were measured at R.T. This dramatic increase
in activity was not observed for any other variant.
Supplemental Information | Sequence alignment of the constructs
discussed. The pNBE sequence corresponds to P37967; it contains
strain-specific differences from the sequence of PDB 1QE3.
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